Literature DB >> 156504

Patterns of neuromuscular disease. As related to stages of normal embryogenesis in voluntary muscle.

A Korényi-Both, G Marosán.   

Abstract

Skeletal muscle samples from the upper and lower extremities of 38 human fetuses (6 to 18 weeks' gestation) of both sexes were studied by histologic, histochemical, and electron microscopic methods. Ultrastructural morphometry was applied. In the different stages of normal development are found regressive changes, ranging from reversible dystrophic to irreversible necrotic alterations, which are characteristic of either primary myogenic myopathies or primary neurogenic muscle atrophies in older age. Several pathologic patterns of so-called congenital myopathies also presented. On the basis of their findings, the authors conclude that in a certain group of congenital myopathies full normal development of muscle is hindered or blocked and that groups of muscles or the whole voluntary musculature is arrested at certain stages of maturation. For example, insufficient or absent innervation of the fetal muscle may be a factor in Werdnig-Hoffmann or Kugelberg-Welander syndromes. The authors' findings suggest that pathologic patterns in muscle diseases have been used physiologically in fetal development to eliminate unnecessary overproduction of muscle fibers.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 156504      PMCID: PMC2042326     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Growth of diseased human muscle in combined cultures with normal mouse embryonic spinal cord.

Authors:  J A Witkowski; V Dubowitz
Journal:  J Neurol Sci       Date:  1975-10       Impact factor: 3.181

2.  [Werdnig-Hoffmann's disease. Study on 53 cases (author's transl)].

Authors:  J M López-Terradas; I Pascual Castroviejo; M Gutiérrez Molina; T Rodríguez Costa
Journal:  An Esp Pediatr       Date:  1975 Jul-Aug

3.  Thick and thin filaments in postmitotic, mononucleated myoblasts.

Authors:  H Holtzer; K Strahs; J Biehl; A P Somlyo; H Ishikawa
Journal:  Science       Date:  1975-05-30       Impact factor: 47.728

4.  Improved localization of phosphorylase by the use of polyvinyl pyrrolidone and high substrate concentration.

Authors:  O ERANKO; A PALKAMA
Journal:  J Histochem Cytochem       Date:  1961-09       Impact factor: 2.479

5.  [Congenital desproportion of various types of muscle fiber, with relative small size of type I fibers. Morphological documents on muscle biopsies in 3 members of the same family].

Authors:  M Fardeau; J P Harpey; B Caille
Journal:  Rev Neurol (Paris)       Date:  1975-11       Impact factor: 2.607

6.  Congenital myopathy with "reducing bodies" in muscle fibres.

Authors:  F M Tomé; M Fardeau
Journal:  Acta Neuropathol       Date:  1975       Impact factor: 17.088

7.  Morphological differences between the atrophied small muscle fibres in amyotrophic lateral sclerosis and Werdnig-Hoffmann disease.

Authors:  A Fidziańska
Journal:  Acta Neuropathol       Date:  1976-04-26       Impact factor: 17.088

8.  Maturational arrest of fetal muscle in neonatal myotonic dystrophy. A pathologic study of four cases.

Authors:  H B Sarnat; S W Silbert
Journal:  Arch Neurol       Date:  1976-07

9.  [Congenital centronuclear myopathy. Two morphological variants in one family (author's transl)].

Authors:  D Pongratz; A Weindl; W Reichl; C Koppenwallner; M Heuser; G Hübner
Journal:  Klin Wochenschr       Date:  1976-05-01

10.  Satellite cell of skeletal muscle fibers.

Authors:  A MAURO
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  2 in total

1.  Ultrastructural aspects of myogenesis found in neoplasms.

Authors:  F P Prince
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

2.  Thyrotoxic myopathy. Pathomorphological observations of human material and experimentally induced thyrotoxicosis in rats.

Authors:  A Korényi-Both; I Korényi-Both; B C Kayes
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.